Bank of America
VTVT icon

Bank of America’s vTv Therapeutics VTVT Stock Holding History

Bank of America’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4
Closed -$160 – 6900
2025
Q4 		$160 Buy
4
+3
+300% +$84 ﹤0.01% 6741
2025
Q3 		$23 Sell
1
-11
-92% -$193 ﹤0.01% 8148
2025
Q2 		$180 Buy
12
+2
+20% +$37 ﹤0.01% 7859
2025
Q1 		$173 Buy
10
+2
+25% +$33 ﹤0.01% 7720
2024
Q4 		$110 Hold
8
– – ﹤0.01% 7719
2024
Q3 		$109 Hold
8
– – ﹤0.01% 7704
2024
Q2 		$141 Sell
8
-68
-89% -$1.62K ﹤0.01% 7637
2024
Q1 		$1.79K Buy
76
+75
+7,500% +$954 ﹤0.01% 7139
2023
Q4 		$12 Sell
1
-8
-89% -$112 ﹤0.01% 7754
2023
Q3 		$180 Buy
+9
New +$220 ﹤0.01% 7420
2023
Q1 		– Sell
-2
Closed -$46 – 8308
2022
Q4 		$46 Buy
+2
New +$66 ﹤0.01% 7818
2022
Q1 		– Sell
-556
Closed -$22K – 8801
2021
Q4 		$22K Buy
556
+555
+55,500% +$29.8K ﹤0.01% 7488
2021
Q3 		$0 Sell
1
-42
-98% -$3.17K ﹤0.01% 8420
2021
Q2 		$4K Sell
43
-381
-90% -$38.6K ﹤0.01% 7466
2021
Q1 		$48K Buy
424
+363
+595% +$35.7K ﹤0.01% 6650
2020
Q4 		$5K Buy
61
+28
+85% +$2.15K ﹤0.01% 6830
2020
Q3 		$2K Sell
33
-106
-76% -$9.32K ﹤0.01% 6713
2020
Q2 		$12K Sell
139
-43
-24% -$4.25K ﹤0.01% 6395
2020
Q1 		$14K Sell
182
-3,047
-94% -$293K ﹤0.01% 6272
2019
Q4 		$220K Buy
3,229
+3,208
+15,276% +$195K ﹤0.01% 5583
2019
Q3 		$1K Sell
21
-7,964
-100% -$450K ﹤0.01% 7142
2019
Q2 		$457K Buy
7,985
+7,875
+7,159% +$473K ﹤0.01% 5130
2019
Q1 		$8K Buy
+110
New +$10.7K ﹤0.01% 6710
2018
Q4 		– Sell
-2
Closed – – 7406
2018
Q3 		$0 Sell
2
-152
-99% -$7.13K ﹤0.01% 7488
2018
Q2 		$9K Buy
154
+140
+1,000% +$10.3K ﹤0.01% 6690
2018
Q1 		$2K Sell
14
-7
-33% -$1.71K ﹤0.01% 6911
2017
Q4 		$5K Buy
21
+13
+163% +$2.92K ﹤0.01% 6739
2017
Q3 		$2K Hold
8
– – ﹤0.01% 6877
2017
Q2 		$2K Sell
8
-26
-76% -$5.42K ﹤0.01% 6760
2017
Q1 		$9K Buy
34
+8
+31% +$1.82K ﹤0.01% 6567
2016
Q4 		$5K Buy
26
+16
+160% +$3.68K ﹤0.01% 6710
2016
Q3 		$3K Buy
10
+4
+67% +$963 ﹤0.01% 6750
2016
Q2 		$2K Buy
6
+3
+100% +$690 ﹤0.01% 6915
2016
Q1 		$1K Sell
3
-3
-50% -$747 ﹤0.01% 6880
2015
Q4 		$1K Sell
6
-35
-85% -$9.82K ﹤0.01% 7205
2015
Q3 		$11K Buy
+41
New +$14.3K ﹤0.01% 6530

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Bank of America's VTVT Position: Q1 2026 in Review

Bank of America sold out of vTv Therapeutics (VTVT) in Q1 2026, closing a stake of 4 shares — an estimated $160 sold.

Bank of America first reported a position in VTVT in Q3 2015 and held it in 36 quarters. The position peaked at $457K in Q2 2019. 35 funds tracked by Wall St. Rank hold VTVT as of Q1 2026.

  • Bank of America reported no remaining vTv Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 4 vTv Therapeutics shares in Q1 2026, an estimated $160.
  • Bank of America first reported a position in vTv Therapeutics in Q3 2015 and held it in 36 quarters.
  • Bank of America's vTv Therapeutics position peaked at $457K in Q2 2019.
  • 35 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.